Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eribulin vs vinorelbine in previously treated metastatic breast cancer (China)
CTR20130252Phase 3Active
- Sponsor
- Eisai Co., Ltd.
- Start
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of eribulin in breast cancer, sponsored by Eisai Co., Ltd.. Started Oct 2014; status: active.
02
Drugs
eribulin
03
Conditions
breast cancer
Beyond the preview
Go deeper on CTR20130252.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20130252.